Remillard
David Remillard
Principal Scientist, Novartis
Enrollment Year - 2013
Bradner and Gray Labs - Dana Farber Cancer Institute

Advisors: James Bradner and Nathanael Gray

Dissertation Title: Chemical Tools to Study Bromodomains in Cancer